PPI Use Tied to Increased Risk of Gastric Polyps

New research from Clinical Gastroenterology and Hepatology shows long-term proton pump inhibitor (PPI) use is associated with increased risk of fundic gland polyps (FGPs), and may be associated with gastric cancer.